Sun Pharmaceuticals Industries (BOM:524715) E10: ₹30.58 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524715 Sun Pharmaceuticals Industries Ltd BOM:524715
91 GF Score
Price ₹1,973.50
GF Value ₹1,927.98
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Sun Pharmaceuticals Industries E10?

Sun Pharmaceuticals Industries BOM:524715 +1.67% 91 E10 is ₹30.58 as of Mar. 2026. GuruFocus rates BOM:524715 with a GF Score™ of 91/100 and a GF Value™ of ₹1,927.98 (Fairly Valued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Sun Pharmaceuticals Industries's adjusted earnings per share data for the three months ended in Mar. 2026 was ₹11.300. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹30.58 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Sun Pharmaceuticals Industries's average E10 Growth Rate was 10.80% per year. During the past 3 years, the average E10 Growth Rate was 6.30% per year. During the past 5 years, the average E10 Growth Rate was 6.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Sun Pharmaceuticals Industries was 7.20% per year. The lowest was 0.80% per year. And the median was 6.30% per year.

As of today (2026-07-28), Sun Pharmaceuticals Industries's current stock price is ₹1973.50. Sun Pharmaceuticals Industries's E10 for the quarter that ended in Mar. 2026 was ₹30.58. Sun Pharmaceuticals Industries's Shiller PE Ratio of today is 64.54.

During the past 13 years, the highest Shiller PE Ratio of Sun Pharmaceuticals Industries was 67.80. The lowest was 14.42. And the median was 38.82.


Sun Pharmaceuticals Industries  (BOM:524715) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Sun Pharmaceuticals Industries's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=1973.50/30.58
=64.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Sun Pharmaceuticals Industries was 67.80. The lowest was 14.42. And the median was 38.82.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Sun Pharmaceuticals Industries E10 Related Terms


Sun Pharmaceuticals Industries E10 Historical Data

* Premium members only.

The historical data trend for Sun Pharmaceuticals Industries's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sun Pharmaceuticals Industries E10 Chart

Sun Pharmaceuticals Industries Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.87 25.47 28.05 27.62 30.58

Sun Pharmaceuticals Industries Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.62 28.60 29.66 30.22 30.58

BOM:524715 vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Sun Pharmaceuticals Industries's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sun Pharmaceuticals Industries Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sun Pharmaceuticals Industries's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Sun Pharmaceuticals Industries's Shiller PE Ratio falls into.


BOM:524715
91GF Score
Sun Pharmaceuticals Industries Ltd BOM:524715
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sun Pharmaceuticals Industries E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sun Pharmaceuticals Industries's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=11.3/164.2724*164.2724
=11.300

Current CPI (Mar. 2026) = 164.2724.

Sun Pharmaceuticals Industries Quarterly Data

per share eps CPI Adj_EPS
201606 8.400 105.961 13.023
201609 9.300 105.961 14.418
201612 6.100 105.196 9.526
201703 5.200 105.196 8.120
201706 -1.770 107.109 -2.715
201709 3.800 109.021 5.726
201712 1.340 109.404 2.012
201803 5.500 109.786 8.230
201806 4.410 111.317 6.508
201809 -1.120 115.142 -1.598
201812 5.180 115.142 7.390
201903 2.640 118.202 3.669
201906 5.780 120.880 7.855
201909 4.430 123.175 5.908
201912 3.810 126.235 4.958
202003 1.670 124.705 2.200
202006 -6.900 127.000 -8.925
202009 7.600 130.118 9.595
202012 7.700 130.889 9.664
202103 3.700 131.771 4.613
202106 6.000 134.084 7.351
202109 8.500 135.847 10.279
202112 8.600 138.161 10.225
202203 -9.500 138.822 -11.242
202206 8.600 142.347 9.925
202209 9.400 144.661 10.674
202212 9.000 145.763 10.143
202303 8.300 146.865 9.284
202306 8.400 150.280 9.182
202309 9.900 151.492 10.735
202312 10.500 152.924 11.279
202403 11.100 153.035 11.915
202406 11.800 155.789 12.443
202409 12.700 157.882 13.214
202412 12.100 158.323 12.555
202503 9.000 157.552 9.384
202506 9.500 159.755 9.769
202509 13.000 162.289 13.159
202512 14.000 163.281 14.085
202603 11.300 164.272 11.300

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹30.58 mean?
Sun Pharmaceuticals Industries (BOM:524715) has a E10 of ₹30.58 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Sun Pharmaceuticals Industries and its competitors.
Is Sun Pharmaceuticals Industries' E10 too high?
Sun Pharmaceuticals Industries' current E10 is ₹30.58. Overall, Sun Pharmaceuticals Industries has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sun Pharmaceuticals Industries' E10 compare to ZTS and UTHR?
Sun Pharmaceuticals Industries' E10 of ₹30.58 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Sun Pharmaceuticals Industries and its competitors. Sun Pharmaceuticals Industries's current E10 is ₹30.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sun Pharmaceuticals Industries stock overvalued right now?
Based on GuruFocus' analysis, Sun Pharmaceuticals Industries (BOM:524715) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,927.98, compared to a current price of ₹1,973.50 — trading 2.4% above its estimated fair value. The current E10 is ₹30.58. Sun Pharmaceuticals Industries' overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Sun Pharmaceuticals Industries (BOM:524715), the current E10 is ₹30.58 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sun Pharmaceuticals Industries (BOM:524715) Overvalued in 2026?

Based on GuruFocus' analysis, Sun Pharmaceuticals Industries stock appears to be overvalued. The current stock price of ₹1,973.50 is trading 2.4% above its estimated GF Value™ of ₹1,927.98. GuruFocus considers Sun Pharmaceuticals Industries to be Fairly Valued.

Key valuation signals for BOM:524715:

  • E10: ₹30.58
  • GF Value™: ₹1,927.98 vs. price of ₹1,973.50 (2.4% above fair value)
  • GF Score™: 91/100 with 3 warning signs

No single metric tells the full story. See the BOM:524715 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sun Pharmaceuticals Industries Business Description

Other Exchanges SUNPHARMA:India
Address Western Express Highway, Sun House, Plot No. 201 B/1, Goregaon (East), Mumbai, MH, IND, 400 063
Sun Pharmaceuticals Industries Ltd is India's generic pharmaceutical manufacturing company. The company's substantial markets are the U.S. and India to make up the majority of revenue. The remaining is spread across both emerging and developed markets. In addition to generics, the company also produces and distributes name-brand formulas to specific geographies. It maintains manufacturing and research and development facilities globally to serve its markets but is majorly based in India.
91GF Score

Get the complete analysis for BOM:524715

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,973.50
Price
₹1,927.98
GF Value